Published in Hepatology on July 29, 2014
An update of clinical management of acute intermittent porphyria. Appl Clin Genet (2015) 0.94
Protoporphyrin IX: the Good, the Bad, and the Ugly. J Pharmacol Exp Ther (2015) 0.80
Role of delta-aminolevulinic acid in the symptoms of acute porphyria. Am J Med (2014) 0.80
Acute Hepatic Porphyria. J Clin Transl Hepatol (2015) 0.80
Liver Fibrosis Associated with Iron Accumulation Due to Long-Term Heme-Arginate Treatment in Acute Intermittent Porphyria: A Case Series. JIMD Rep (2015) 0.78
Pitfalls in Erythrocyte Protoporphyrin Measurement for Diagnosis and Monitoring of Protoporphyrias. Clin Chem (2015) 0.75
Liver transplantation for pediatric inherited metabolic disorders: Considerations for indications, complications, and perioperative management. Pediatr Transplant (2016) 0.75
Intermediate filament proteins of digestive organs: Physiology and pathophysiology. Am J Physiol Gastrointest Liver Physiol (2017) 0.75
Acute Hepatic Porphyrias: Recommendations for Evaluation and Long Term Management. Hepatology (2017) 0.75
A mouse model of hereditary coproporphyria identified in an ENU mutagenesis screen. Dis Model Mech (2017) 0.75
Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med (2005) 2.95
Erythropoietic protoporphyria and pretransplantation treatment with nonbiological liver assist devices. Liver Transpl (2007) 2.74
Screening for hepatocellular carcinoma in acute intermittent porphyria: a 15-year follow-up in northern Sweden. J Intern Med (2010) 2.30
Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl (2005) 1.76
Controlled trial of haem arginate in acute hepatic porphyria. Lancet (1989) 1.75
C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet (2008) 1.64
Low-dose hydroxychloroquine is as effective as phlebotomy in treatment of patients with porphyria cutanea tarda. Clin Gastroenterol Hepatol (2012) 1.47
Evidence for neurological dysfunction in end-stage protoporphyric liver disease. Hepatology (1993) 1.44
Plasma and red cell exchange transfusions for erythropoietic protoporphyria: a case report and review of the literature. J Clin Apher (2012) 1.40
Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A (1971) 1.33
Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut (2007) 1.31
Liver transplantation for porphyria: who, when, and how? Liver Transpl (2007) 1.29
Liver transplantation as a cure for acute intermittent porphyria. Lancet (2004) 1.26
Inheritance in erythropoietic protoporphyria: a common wild-type ferrochelatase allelic variant with low expression accounts for clinical manifestation. Blood (1999) 1.21
Transitory renal failure following rapid administration of a relatively large amount of hematin in a patient with acute intermittent porphyria in clinical remission. Acta Med Scand (1978) 1.17
Open-label study of hemin for acute porphyria: clinical practice implications. Am J Med (2006) 1.07
Combined liver and kidney transplantation in acute intermittent porphyria. Transpl Int (2009) 1.05
Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem (1989) 1.05
Protoporphyrin retention in hepatocytes and Kupffer cells prevents sclerosing cholangitis in erythropoietic protoporphyria mouse model. Gastroenterology (2011) 1.03
Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation. J Clin Invest (1998) 1.02
Liver transplantation for acute intermittent porphyria is complicated by a high rate of hepatic artery thrombosis. Liver Transpl (2012) 0.97
Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease. Cell Mol Biol (Noisy-le-grand) (2002) 0.96
Highly heterogeneous nature of delta-aminolevulinate dehydratase (ALAD) deficiencies in ALAD porphyria. Blood (2001) 0.95
Birefringence of hepatic pigment deposits in erythropoietic protoporphyria. Specificity of polarization microscopy in the identification of hepatic protoporphyrin deposits. Gastroenterology (1974) 0.94
An appraisal of pediatric liver transplantation from living relatives. Initial clinical experiences in 20 pediatric liver transplantations from living relatives as donors. Ann Surg (1992) 0.94
Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria. Gastroenterology (1999) 0.94
Early involvement of hepatic parenchymal cells in erythrohepatic protoporphyria? An ultrastructural study of patients with and without overt liver disease and the effect of chenodeoxycholic acid treatment. Hepatology (1990) 0.94
Recovery from a variegate porphyria by a liver transplantation. Liver Transpl (2004) 0.94
Renal symptomatology in patients with acute intermittent porphyria. A population-based study. J Intern Med (2000) 0.93
The porphyrias. Dis Mon (1989) 0.92
Hepatic complications of erythropoietic protoporphyria. Photodermatol Photoimmunol Photomed (1998) 0.91
Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis. J Hepatol (2006) 0.91
Genotypic determinants of phenotype in North American patients with erythropoietic protoporphyria. Mol Genet Metab (2003) 0.90
Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria. Pediatrics (2006) 0.89
delta-Aminolevulinate dehydratase (ALAD) porphyria: the first case in North America with two novel ALAD mutations. Mol Genet Metab (2005) 0.89
A genotype-phenotype correlation between null-allele mutations in the ferrochelatase gene and liver complication in patients with erythropoietic protoporphyria. Cell Mol Biol (Noisy-le-grand) (2002) 0.89
Liver Transplantation because of Acute Liver Failure due to Heme Arginate Overdose in a Patient with Acute Intermittent Porphyria. Case Rep Gastroenterol (2012) 0.88
A gonadotropin releasing hormone analogue prevents cyclical attacks of porphyria. Arch Intern Med (1990) 0.86
Erythropoietic protoporphyria with hepatic cirrhosis. Arch Dermatol (1980) 0.86
Review of hepatocellular cancer, hypertension and renal impairment as late complications of acute porphyria and recommendations for patient follow-up. J Clin Pathol (2012) 0.86
The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria. Transplantation (1999) 0.86
Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria. Liver Transpl (2008) 0.84
Ultrastructural study of the liver in hepatic prophyria. J Clin Pathol (1968) 0.84
Fecal protoporphyrin excretion in erythropoietic protoporphyria: effect of cholestyramine and bile acid feeding. Gastroenterology (1988) 0.83
Biochemical and genetic characterization of four cases of hereditary coproporphyria in Spain. Mol Genet Metab (2005) 0.82
Effect of hematin administration to patients with protoporphyria and liver disease. Hepatology (1983) 0.82
Neurovisceral porphyrias: what a hematologist needs to know. Hematology Am Soc Hematol Educ Program (2005) 0.81
Recessive inheritance of erythropoietic protoporphyria with liver failure. Lancet (1994) 0.80
Structure-function relationships of protoporphyrin-induced liver injury. Arch Pathol Lab Med (1984) 0.80
Liver transplantation for erythropoietic protoporphyria in Europe. Liver Transpl (2011) 0.80
Photosensitivity and perioperative polyneuropathy complicating orthotopic liver transplantation in a patient with erythropoietic protoporphyria. Anesthesiology (1999) 0.80
Hepatic complications of erythropoietic protoporphyria. Br J Dermatol (1994) 0.79
The role for BMT in erythropoietic protoporphyria. Bone Marrow Transplant (2009) 0.79
Living-related liver transplantation for inborn errors of metabolism. Transplant Proc (1994) 0.77
Combined valve and coronary surgery in a patient with erythropoietic protoporphyria. J Card Surg (2005) 0.77
Liver transplantation in a boy with acute porphyria due to aminolaevulinate dehydratase deficiency. Eur J Clin Chem Clin Biochem (1992) 0.77
Delayed immune recovery following sequential orthotopic liver transplantation and haploidentical stem cell transplantation in erythropoietic protoporphyria. Pediatr Transplant (2009) 0.76
Acute liver failure in children: the first 348 patients in the pediatric acute liver failure study group. J Pediatr (2006) 3.03
Intensive care of patients with acute liver failure: recommendations of the U.S. Acute Liver Failure Study Group. Crit Care Med (2007) 2.17
Prospective, randomized, multicenter, controlled trial of a bioartificial liver in treating acute liver failure. Ann Surg (2004) 1.79
Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci (2003) 1.72
Retransplantation for hepatitis C: results of a U.S. multicenter retransplant study. Liver Transpl (2007) 1.54
The legitimacy of leadership in international climate change negotiations. Ambio (2012) 1.50
Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases. Electrophoresis (2007) 1.26
Multicenter clinical experience with the Afirma gene expression classifier. J Clin Endocrinol Metab (2013) 1.13
Cholestatic liver injury associated with whey protein and creatine supplements. Semin Liver Dis (2008) 1.08
In vitro activity of CEM-101, a new fluoroketolide antibiotic, against Chlamydia trachomatis and Chlamydia (Chlamydophila) pneumoniae. Antimicrob Agents Chemother (2009) 1.07
Costs of telaprevir-based triple therapy for hepatitis C: $189,000 per sustained virological response. Hepatology (2014) 1.05
Porphyrin and heme metabolism and the porphyrias. Compr Physiol (2013) 1.01
Urinary biomarkers of IgA nephropathy and other IgA-associated renal diseases. World J Urol (2007) 0.97
Genetic aspects of porphyria cutanea tarda. Semin Liver Dis (2007) 0.93
Current trends in the treatment of hepatic encephalopathy. Ther Clin Risk Manag (2009) 0.90
Use of preserved vascular homografts in liver transplantation: hepatic artery aneurysms and other complications. Am J Transplant (2002) 0.89
Clonal analyses define the relationships between chromosomal abnormalities and JAK2V617F in patients with Ph-negative myeloproliferative neoplasms. Exp Hematol (2009) 0.84
Implementation of vaccination in patients with cirrhosis. Dig Dis Sci (2002) 0.82
Hepatic assist devices: will they ever be successful? Curr Gastroenterol Rep (2009) 0.80
Placenta growth factor induces invasion and activates p70 during rapamycin treatment in trophoblast cells. Am J Reprod Immunol (2014) 0.80
Outpatient management of cirrhosis: a narrative review. South Med J (2006) 0.80
Gastric antral vascular ectasia: a rare manifestation for gastrointestinal bleeding in left ventricular assist device patients--an initial report. Dig Dis Sci (2014) 0.80
An escalating dose regimen of pegylated interferon and ribavirin in HCV cirrhotic patients referred for liver transplant. Transplantation (2009) 0.78
Hepatic encephalopathy: a review of its pathophysiology and treatment. Curr Treat Options Gastroenterol (2006) 0.78
Surveillance for hepatocellular carcinoma: evidence, guidelines and utilization. Am J Med Sci (2014) 0.77
Comparing the aspartate aminotransferase (AST) to platelet ratio index (APRI) between African American and White veterans with chronic hepatitis C. South Med J (2011) 0.76
HFE hemochromatosis and hepatic sarcoid. Am J Med Sci (2009) 0.76
Two-dose daclizumab induction therapy in 209 liver transplants: a single-center analysis. Transplantation (2004) 0.76
Use of extracorporeal albumin dialysis for erythropoietic protoporphyria. Liver Transpl (2007) 0.76
Telaprevir and boceprevir in African Americans with genotype 1 chronic hepatitis C: implications for patients and providers. South Med J (2012) 0.76
Editorial comment: liver transplantation. Curr Opin Organ Transplant (2009) 0.75
Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipients. Liver Int (2009) 0.75
Orthotopic liver transplantation changes the course of gastric antral vascular ectasia: a case series from a transplant center. Eur J Gastroenterol Hepatol (2017) 0.75
Pilot debrief. Lessons learned assisting physician practices adopt health IT. J AHIMA (2007) 0.75
A biopsychosocial approach to liver transplant evaluation in two patients with Wilson's disease. Psychol Health Med (2011) 0.75
Intermittent unexplained abdominal pain: is it porphyria? Clin Gastroenterol Hepatol (2007) 0.75
A pilot study examining the safety and tolerability of valacyclovir in veterans with hepatitis C virus/herpes simplex virus type 2 coinfection. Am J Med Sci (2014) 0.75